DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer
NCT ID: NCT00400426
Last Updated: 2013-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
100 participants
INTERVENTIONAL
2006-11-30
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC
NCT02976051
Palliative Radiotherapy Protocol in Head and Neck Cancer
NCT02460471
Short Course Radiation Therapy in Palliative Treatment
NCT03196700
Comparing Two Palliative Schemes of Radiotherapy for Head and Neck Cancer
NCT02421458
Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
NCT03742687
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radiotherapy
20 Gy in 4 fx
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Speaks and reads Danish
* Capable of filling out questionnaires for at leas two months after radiotherapy
* Age\>=18 years
* Expected survival\> 3months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danish Head and Neck Cancer Group
NETWORK
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kenneth Jensen
MD ph.d.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenneth Jensen, MD
Role: PRINCIPAL_INVESTIGATOR
DAHANCA (Danish Head and Neck Cancer Group)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Oncology
Aarhus, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DAHANCA 20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.